DE2739659C3 - N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung - Google Patents

N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung

Info

Publication number
DE2739659C3
DE2739659C3 DE2739659A DE2739659A DE2739659C3 DE 2739659 C3 DE2739659 C3 DE 2739659C3 DE 2739659 A DE2739659 A DE 2739659A DE 2739659 A DE2739659 A DE 2739659A DE 2739659 C3 DE2739659 C3 DE 2739659C3
Authority
DE
Germany
Prior art keywords
aminopyrimidine
dichlorophenyl
preparation
dap
bor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2739659A
Other languages
German (de)
English (en)
Other versions
DE2739659A1 (de
DE2739659B2 (de
Inventor
Andre Paris Esanu
Original Assignee
Société d'Etudes de Produits Chimiques S.A., Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société d'Etudes de Produits Chimiques S.A., Paris filed Critical Société d'Etudes de Produits Chimiques S.A., Paris
Publication of DE2739659A1 publication Critical patent/DE2739659A1/de
Publication of DE2739659B2 publication Critical patent/DE2739659B2/de
Application granted granted Critical
Publication of DE2739659C3 publication Critical patent/DE2739659C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE2739659A 1976-09-03 1977-09-02 N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung Expired DE2739659C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB36523/76A GB1534593A (en) 1976-09-03 1976-09-03 N-2,6-dichlorophenyl-2-aminopyrimidine and therapeutic compositions containing it

Publications (3)

Publication Number Publication Date
DE2739659A1 DE2739659A1 (de) 1978-03-09
DE2739659B2 DE2739659B2 (de) 1979-10-04
DE2739659C3 true DE2739659C3 (de) 1987-09-10

Family

ID=10388933

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2739659A Expired DE2739659C3 (de) 1976-09-03 1977-09-02 N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung

Country Status (28)

Country Link
US (1) US4100287A (enExample)
JP (1) JPS5331681A (enExample)
AR (1) AR212375A1 (enExample)
AT (1) AT353797B (enExample)
AU (1) AU509295B2 (enExample)
BE (1) BE857992A (enExample)
CA (1) CA1079732A (enExample)
CH (1) CH622251A5 (enExample)
DE (1) DE2739659C3 (enExample)
DK (1) DK142847B (enExample)
EG (1) EG12895A (enExample)
ES (1) ES462071A1 (enExample)
FI (1) FI63564C (enExample)
FR (2) FR2363560A1 (enExample)
GB (1) GB1534593A (enExample)
HK (1) HK59179A (enExample)
IE (1) IE45480B1 (enExample)
LU (1) LU77999A1 (enExample)
MX (1) MX4997E (enExample)
MY (1) MY8000098A (enExample)
NL (1) NL163782C (enExample)
NO (1) NO145790C (enExample)
NZ (1) NZ184908A (enExample)
OA (1) OA05751A (enExample)
PH (1) PH15051A (enExample)
PT (1) PT66991B (enExample)
SE (1) SE442635B (enExample)
ZA (1) ZA774842B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
NZ566862A (en) * 2005-09-27 2010-12-24 Irm Llc Diarylamine-containing compounds and compositions, and their use as modulators of C-kit receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
DE1670537A1 (de) * 1966-11-09 1970-10-29 Degussa Verfahren zur Herstellung neuer substituierter Aminopyrimidine
US3481932A (en) * 1967-09-01 1969-12-02 Searle & Co 2-anilino-5-methyl-6-phenylpyrimidines and congeners
DE1958212C3 (de) * 1969-11-19 1978-12-07 C.H. Boehringer Sohn, 6507 Ingelheim Substituierte 2- [N-(2-Chlorphenyl)-N-(cycloalkyl)amino] -imidazoline- (2), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung
CH593266A5 (enExample) * 1973-09-20 1977-11-30 Delalande Sa

Also Published As

Publication number Publication date
FR2363561B1 (enExample) 1980-05-16
FR2363560A1 (fr) 1978-03-31
BE857992A (fr) 1977-12-16
NL7709272A (nl) 1978-03-07
PT66991B (en) 1979-02-13
FR2363561A1 (fr) 1978-03-31
FI63564B (fi) 1983-03-31
CH622251A5 (enExample) 1981-03-31
EG12895A (en) 1980-03-31
SE442635B (sv) 1986-01-20
IE45480B1 (en) 1982-09-08
GB1534593A (en) 1978-12-06
AU2852377A (en) 1979-03-08
NZ184908A (en) 1978-11-13
AU509295B2 (en) 1980-05-01
NL163782C (nl) 1980-10-15
US4100287A (en) 1978-07-11
MY8000098A (en) 1980-12-31
DK142847C (enExample) 1981-09-21
SE7709852L (sv) 1978-03-04
HK59179A (en) 1979-08-31
ATA585477A (de) 1979-05-15
DE2739659A1 (de) 1978-03-09
NO773039L (no) 1978-03-06
ZA774842B (en) 1978-06-28
MX4997E (es) 1983-02-02
CA1079732A (en) 1980-06-17
NO145790C (no) 1982-06-02
DK142847B (da) 1981-02-09
JPS5422993B2 (enExample) 1979-08-10
FR2363560B1 (enExample) 1980-05-16
PH15051A (en) 1982-05-20
ES462071A1 (es) 1978-06-01
DE2739659B2 (de) 1979-10-04
IE45480L (en) 1978-03-03
LU77999A1 (enExample) 1978-01-11
OA05751A (fr) 1981-05-31
FI63564C (fi) 1983-07-11
DK391377A (enExample) 1978-03-04
NL163782B (nl) 1980-05-16
AT353797B (de) 1979-12-10
PT66991A (en) 1977-10-01
AR212375A1 (es) 1978-06-30
JPS5331681A (en) 1978-03-25
FI772503A7 (fi) 1978-03-04
NO145790B (no) 1982-02-22

Similar Documents

Publication Publication Date Title
DE19542281C2 (de) Verwendung von Epinastin für die Behandlung der Migräne
DE2810918C2 (de) Taurin-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2167157C2 (de) 4-Substituierte-2-halogen-6,7,8-trimethoxychinazoline
EP0136470B1 (de) Injizierbare Lösung zur Behandlung von Entzündungen
DE2310918B2 (de) 3-lsobutoxy-2-pyrrolidino-N-phenyl-N-benzylpropylamin, dessen Salze, Verfahren zu deren Herstellung und Arzneimittel
EP0240829A2 (de) Cancerostatisches Mittel
DE3037770C2 (de) N-Niedrigalkyl-3-phenoxy-1-azetidincarboxamide und diese Verbindungen enthaltende Zubereitungen
DE3522506A1 (de) Derivate von glutaminsaeure und asparaginsaeure mit antagonistischer wirkung gegen bioaktive polypeptide und verfahren zu ihrer herstellung
EP0752246A2 (de) Kappa-Opiate für entzündliche Darmerkrankungen
DE2720545C3 (de) Derivate des 2,4-Diamino-6,7-dimethoxychinazolins, ihre Herstellung und pharmazeutische Mittel
DE3009071A1 (de) 2-isopropylaminopyrimidinhydroxyderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
DE2739659C3 (de) N-2,6-Dichlorphenyl-2-aminopyrimidin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE69104054T2 (de) Melatoninderivat mit therapeutischer aktivität, das in der dermatologie anwendbar ist.
DE1695428B2 (de) Derivate des 5-mercaptopyridoxins und verfahren zu deren herstellung
DE2656602A1 (de) 2-hydroxymethyl-3,4,5-trihydroxypiperidin, extraktionsverfahren zu seiner herstellung und seine verwendung als arzneimittel
DE3026053C2 (de) 2-substituierte-4-Thiazolidone
DE2110537C3 (de) N-Pyridyl-brenzschleimsäureamide, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE2946613C2 (de) trans-2-Amido-hexahydrobenzo[a]chinolizine und Arzneimittel, welche diese enthalten
DE3238305C2 (enExample)
DE2030693C3 (de) Säureadditionssalze von N-p-Methoxybenzyl-N', N"-dimethylguanidin, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
AT338781B (de) Verfahren zur herstellung neuer 1,3-benzodioxol-derivate und ihrer salze
DE2621227C3 (de) Nichtdepolarisierendes Myorelaxans
DE2501649B2 (de) Thiophen-2-carbonsäuresalze des Papaverine, Verfahren zu seiner Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0461218B1 (de) Zubereitung eines salzes von oxypurinol in oraler form zur behandlung von hyperuricämie

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
8278 Suspension cancelled
8281 Inventor (new situation)

Free format text: ESANU, ANDRE, PARIS, FR

C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee